Company attributes
B2X
Founder
Legal Name
Eyevensys S.A.S.
Date Incorporated
2008
Spun Out From
Number of Employees (Ranges)
11 – 50
Email Address
contact@eyevensys.com
Phone Number
+33184791060
Full Address
Biopark 11 Rue Watt Bat B 75013 Paris France
Investors
Founded Date
2008
Total Funding Amount (USD)
54,000,000
Latest Funding Round Date
August 9, 2021
Latest Funding Type
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
12,000,000
Eyevensys is a biotech company that offers a new approach to treating major ophthalmic conditions through gene therapy and protein delivery. The company has a technology that enables therapeutic proteins to be produced inside the eye—by the eye itself—providing long-lasting medical treatment effects.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
